OKYO OKYO Pharma Limited - Ordinary Shares
$1.53
Price · Aug 24, 2026
52W Range
$1–$3
10% of range
Analyst Rating
BUY
9 analysts
Price Target
$8
+445% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
OKYO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.53
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $3
OKYO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
OKYO
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
OKYO
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
OKYO
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
OKYO
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
OKYO
Peer Median
OKYO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 2 22.2%
- Buy 6 66.7%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-08-18
Median
$7.00
Mean
$8.33
← Below all targets
$1.53
Low
$5.00
High
$13.00
Median target
$7.00
+357.5%
Mean target
$8.33
+444.6%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OKYO | — | — | — | — | — | — |
| BCYC | $491M | -2.2 | 105.8% | -301.7% | -34.2% | — |
| TLSA | — | — | — | — | — | — |
| MREO | $332M | -8.3 | — | -8375.6% | -88.1% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 19 filers · $9.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (+4 vs prior Q) | 1 (0 vs prior Q) | 3 (+1 vs prior Q) | 3 (+2 vs prior Q) | +96K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Woodline Partners LP | $5,479,152 | 3,652,768 | 56.36% | Shares |
| Stonepine Capital Management, LLC | $1,294,494 | 862,996 | 13.32% | Shares |
| Maven Securities LTD | $1,213,976 | 809,317 | 12.49% | Shares |
| Balyasny Asset Management L.P. | $870,894 | 580,596 | 8.96% | Shares |
| Opaleye Management Inc. | $562,806 | 375,204 | 5.79% | Shares |
| UBS Group AG | $63,918 | 42,612 | 0.66% | Shares |
| XTX Topco Ltd | $56,654 | 37,769 | 0.58% | Shares |
| CHOREO, LLC | $49,883 | 33,255 | 0.51% | Shares |
| Quantinno Capital Management LP | $49,882 | 33,255 | 0.51% | Shares |
| Cerity Partners LLC | $19,218 | 12,812 | 0.20% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $18,135 | 12,090 | 0.19% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $16,800 | 11,200 | 0.17% | Shares |
| JANE STREET GROUP, LLC | $15,453 | 10,302 | 0.16% | Shares |
| Steward Partners Investment Advisory, LLC | $9,000 | 6,000 | 0.09% | Shares |
| EFG International AG | $1,385 | 923 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $228 | 152 | 0.00% | Shares |
| Continuum Advisory, LLC | $75 | 50 | 0.00% | Shares |
| MORGAN STANLEY | $15 | 10 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $4 | 3 | 0.00% | Shares |
Company insiders 9 insiders · 5 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert John Dempsey | CHIEF EXECUTIVE OFFICER | July 22, 2026 P | 15,000 | 1 | 0 | $23,100 |
| Keeren Rameshchandra Shah | Chief Financial Officer | June 8, 2026 A | — | 0 | 0 | $0 |
| Rajkumar V. Patil | Chief Scientific Officer | July 27, 2026 P | 20,030 | 1 | 0 | $5,011 |
| Flavio Mantelli | CHIEF MEDICAL OFFICER | July 21, 2026 P | 20,000 | 1 | 0 | $28,000 |
| Gary S Jacob | CHIEF DEVELOPMENT OFFICER | July 21, 2026 P | 112,420 | 1 | 0 | $4,900 |
| John P Brancaccio | Director | July 21, 2026 P | 35,201 | 1 | 0 | $7,400 |
| Gabriele M Cerrone | Director | July 20, 2026 P | 10,851,416 | 2 | 0 | $67,625 |
| Bernard Denoyer | Director | June 8, 2026 A | — | 0 | 0 | $0 |
| Willy Jules Simon | Director | June 8, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only